Language: 简体中文 English
Abstract Submission
2020 WCBIP Call for Abstracts Announcement

The World Association for Bronchology and Interventional Pulmonology (WABIP) holds a biennial event known as the World Congress for Bronchology and Interventional Pulmonology (WCBIP). The first ever WCBIP was held in 1978 in Tokyo, Japan with Dr. Shigeto Ikeda, inventor of the flexible bronchoscope, as congress president. This landmark event was followed by congresses in host sites rotating around the world.
This time WCBIP will be held in Shanghai, China on November 19-22, 2020 and is co-organized by the Chinese Medical Association and the Chinese Thoracic Society.

Target Audience
Physicians and care providers who care for patients with disorders of the larynx, pharynx, esophagus, and lungs. This event is designed to provide education for otolaryngologists, gastroenterologists, pulmonologists, and thoracic surgeons.

Call for abstracts
The overview of bronchology and interventional pulmonology
Education and training of bronchology and interventional pulmonology
Inovations of bronchology and intervetional pulmonology in the past 20 years
Precisional medicine and interventional pulmonology
AI application in bronchology and interventional pulmonology
Interventional strategy of central airway stenosis
Interventional therapy for COPD
Bronchial thermoplasty of asthma
Pleural diseases and their management
Transthoracic needle biopsy and its application
Early lung cancer treatment
Lung cancer staging
Lung cancer diagnostic technologies
Safety and complciation of bronchoscopic techniques.
The management of tracheal / bronchial fistulas to the esophageal and pleural spaces.
Rare airway diseases
Brachytherapy and other radiotherapy for malignant thoracic conditions.
Difficult airway management  
Airway Stents application, complication and extraction
Rigid vs flexible bronchoscope
The interventional therapy of tracheal or bronchial tuberculosis
The education of bronchology and interventional pulmonology
From bench to bedside: the translational medicine in bronchology and interventional pulmonology
Cross talks between interventional pulmonologist and related disciplines.
Prevention and treatment of Infection during and after bronchoscopic and interventional procedures
Multidisciplinary treatment of lung cancer
Biopsy, re-biopsy in the treatment of lung cancer
Biopsy strategy of lung cancer relating to molecular targeted therapy and immunotherapy
Interventional diagnosis of diffuse parenchymal lung diseases
Anesthesia and interventional pulmonology
Navigation technologies in the diagnosis of pulmonary nodules
Cleaning and disinfection of bronchoscope and thoracoscope
Laboratory technologies relating to bronchology and interventional pulmonology
Case puzzle
Video festival
Pulmonary vascular diseases and interventional therapy
Now WCBIP congress call for excellent papers, approved abstracts will be posted on WABIP website after congress.

(Abstracts may be selected for oral presentation, Poster/e-Poster presentation, published only.)
Upon conclusion of this program, participants should be able to:
 Describe the appropriate strategies for diagnosis, staging, tissue acquisition preparation and interpretation, and treatment, including standard chemotherapy, molecular targeted therapy and immunotherapy, for late stage lung cancer 
 Describe the appropriate evaluation and diagnosis of pulmonary nodules including various navigational technologies, and bronchoscopic ablation technologies. 
 Describe the latest approaches to the diagnosis and management of diffuse lung disease including the use of imaging, cryobiopsies, surgical lung biopsies and anti-fibrotic therapy. 
 Define the proper management of malignant and benign airway diseases including tracheobronchial esophageal fistulas, tracheobronchomalacia, idiopathic subglottic stenosis, and tuberculosis induced stenosis using various airway stents, lasers and surgical options including tracheal transplantation. 
 Describe the appropriate management of pleural diseases including complicated pleural effusions, malignant pleural effusion, empyema, and exudative pleural effusions of uncertain etiology using small bore chest tubes, tunneled pleural catheters, lytic therapy, pleuroscopy and video assisted thoracic surgery. 
  Describe the implementation of a lung cancer screening program in high risk populations. 
 Describe the appropriate evaluation and treatment of various pediatric benign and malignant airway disorders including airway foreign bodies, tracheobronchomalacia, tracheobronchostenosis, and tracheobronchial fistulas. 
 Define the appropriate management of various esophageal disorders including gastroesophageal reflux, esophageal strictures and eosinophilic esophagitis. 
 Describe the management of difficult asthmatics including the use inhalation strategies, monoclonal antibodies and bronchial thermoplasty. 
 Define the use of the various bronchoscopic lung volume reduction devices in the management of severe emphysema. 
 Define the educational requirements for Interventional Pulmonary training programs, and curriculum for pulmonary procedure courses. 
 Describe the evaluation and management strategies for disorders of the mediastinum including fibrosing mediastinitis. 
 Describe the current approaches to management of laryngotracheal stenosis and vocal cord dysfunction. 
 Define the airway complications of lung transplantation and their appropriate management.

All abstract language submissions must be submitted in English.
Length, style, and formatting
 Abstracts should have a clear hypothesis and methodology, list all author names and institutions, and designate a corresponding author.
 The body of text can be a maximum of 400 words and include 1 figure or table as an image file. Tables and figures do not count towards the total word count.
 Abstracts should be written in a structured format and include: Title, Authors names, Authors affiliations, Background, Methods, Results, and Conclusion.
 Case reports are also acceptable and should be identified as such on the submission form. Case reports should be structured as follows: Title, Authors names, Authors affiliations, Background, Case report, and Conclusion.
 The abstracts title should begin with a capital letter followed by lower case lettering.
Oral Presentations
 Oral presentations are 7 minutes with 3 minutes for questions.
 PowerPoint presentations may be used. 
Poster Presentations
 Text, figures, and images may be included.
 Posters may be laminated.
 Recommended size of poster is 80 cm x 160 cm

All abstract language submissions must be submitted in English.
Submission Procedure
 Before submitting your abstract, you have to create a personal account first which will be used for abstract submission and modification.  
 Please use the account and password you have created before to submit another abstract or edit existing abstract (s).  
 You may add additional authors with their institutions and it is important to ensure that they are in the correct order.  
 You will be allowed to review all the information that was entered on each step of the submission process and a green check mark will display at the center of the review step if it was completed successfully.
Once submission is completed, you will automatically receive an E-mail confirming the receipt of your abstract.
 If you do not receive this E-mail within 1 hour after submission, there is a possibility that your submission has not been processed successfully. You may check your submission status using your account or you can contact us at
 Please make sure all the submitted information is accurate before the submission deadline.
 Only the accepted abstracts of fully registered and paid presenters can be included in the final scientific program. The presenting author is expected to attend the conference and present his/her oral or e-Poster presentation.
 Deadline for Abstracts, Wideo Festival extended to: July 31, 2020.

Notification of Acceptance  
All abstracts submitted online will be reviewed by the Scientific Committee.
Abstracts may be selected for oral presentation, Poster/e-Poster presentation, published only.
Information regarding acceptance will be sent to the abstract submitter once confirmed.
Instructions for preparation of oral and e-Poster presentations will be sent together with the acceptance notification.
The first author must present his/her presentation.
The presenting author is required to ensure that all co-authors are aware of the content of the abstract.
Please note that all abstracts accepted for presentation will be published on the website prior to the conference.

Abstract Submission

Important Dates
Conference Dates 
November 19-22, 2020
Submission Deadline
July 31, 2020
Online Registration Deadline
November 15, 2020
On-site Registration starts
November 19, 2020